Advanced Search

Technical Analysis for VOR - Vor Biopharma Inc.

Grade Last Price % Change Price Change
F 44.96 -16.86% -9.12
VOR closed down 16.86 percent on Friday, February 26, 2021, on 64 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical VOR trend table...
Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
New 52 Week Closing High Bullish -16.86%
Pocket Pivot Bullish Swing Setup -16.86%
Multiple of Ten Bullish Other -16.86%
Bullish Engulfing Bullish -15.66%
Morning Star Bullish -15.66%
New 52 Week Closing High Bullish -15.66%
Multiple of Ten Bullish Other -15.66%
Hammer Candlestick Bullish 3.50%
Lizard Bullish Bullish Day Trade Setup 3.50%
Older End-of-Day Signals for VOR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 2 days ago
Fell Below 10 DMA 2 days ago
10 DMA Support 2 days ago
Fell Below Previous Day's Low 2 days ago
Down 10% 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acute Myeloid Leukemia Therapies For Cancer Tyrosine Kinase Receptors Proteins Haematopoiesis

Is VOR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 27 The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Feb 13 The Past Week's Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More
Feb 9 Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
Feb 9 105 Biggest Movers From Yesterday
Feb 5 Cell therapy biotech Vor Biopharma prices upsized IPO at $18/share, trades today
Feb 5 PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering
Feb 5 Vor Biopharma Announces Pricing of Initial Public Offering
Feb 2 Vor Biopharma Launches $150 Million IPO
See more VOR news...

Indicators

Indicator Value
52 Week High 63.62
52 Week Low 25.32
Average Volume 322,629
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 48.75
Average True Range 9.75
ADX 0.0
+DI 19.30
-DI 12.30
Chandelier Exit (Long, 3 ATRs ) 34.36
Chandelier Exit (Short, 3 ATRs ) 54.58
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.76
MACD Signal Line 0.37
MACD Histogram 0.392
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.08
Resistance 3 (R3) 57.91 54.71 55.06
Resistance 2 (R2) 54.71 51.62 54.29 54.39
Resistance 1 (R1) 49.83 49.71 48.23 49.00 53.71
Pivot Point 46.63 46.63 45.83 46.21 46.63
Support 1 (S1) 41.75 43.54 40.15 40.92 36.21
Support 2 (S2) 38.55 41.63 38.13 35.53
Support 3 (S3) 33.67 38.55 34.86
Support 4 (S4) 32.84